Search Within

Michael Forman Berger

  1. "Maurizio Scaltriti"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (11)
  3. Research Letter (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (27)
  2. Department of Pathology and Laboratory Medicine (27)
  3. GSK Faculty (27)
  4. Human Oncology and Pathogenesis Program (27)
  5. Department of Medicine (23)
  6. Solid Tumor Oncology Division (23)

More Groups

People
  1. Maurizio Scaltriti (27)
  2. Helen Won (16)
  3. David Solit (15)
  4. David Hyman (14)
  5. Jose Baselga (11)
  6. Emiliano Cocco (9)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2020 (3)
  4. 2019 (5)
  5. 2018 (6)
  6. 2017 (2)

More Years

Publications
  1. Cancer Discovery (5)
  2. Cancer Research (5)
  3. Journal of Clinical Oncology (4)
  4. European Journal of Cancer (2)
  5. Nature (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. American Society of Clinical Oncology (5)
  3. Nature Publishing Group (5)
  4. American Association for the Advancement of Science (2)
  5. Elsevier Inc. (2)
  6. Cell Press (1)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
    Journal Article

    Rosen, E. Y.; Won, H. H.; Zheng, Y.; Cocco, E.; Selcuklu, D.; Gong, Y.; Friedman, N. D.; de Bruijn, I.; Sumer, O.; Bielski, C. M.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
    Journal Article

    Radosevic-Robin, N.; Selenica, P.; Zhu, Y.; Won, H. H.; Berger, M. F.; Ferrando, L.; Cocco, E.; Privat, M.; Ponelle-Chachuat, F.; Abrial, C.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • TRK XDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Journal Article

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arruabarrena-Aristorena, A.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
    Journal Article

    Razavi, P.; Dickler, M. N.; Shah, P. D.; Toy, W.; Brown, D. N.; Won, H. H.; Li, B. T.; Shen, R.; Vasan, N.; Modi, S.; more...
    Nature Cancer (2020)

    Fulltext@MSK | Save
  • HER2-mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers
    Journal Article

    Li, B. T.; Michelini, F.; Misale, S.; Cocco, E.; Baldino, L.; Cai, Y.; Shifman, S.; Tu, H. Y.; Myers, M. L.; Xu, C.; more...
    Cancer Discovery (2020)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Paired tumor and cfDNA in patients with HER2-mutant solid tumors treated with neratinib reveals convergence of multiple on-target resistance mechanisms: Results from the SUMMIT "Basket" Trial
    Meeting Abstract

    Won, H. H.; Selcuklu, S. D.; Piha-Paul, S. A.; Saura, C.; Rodon, J.; Mayer, I. A.; Loi, S.; Shapiro, G. I.; Lu, J.; Brufsky, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAP kinase pathway activation
    Meeting Abstract

    Cocco, E.; Kulick, A.; Misale, S.; Yaeger, R.; Razavi, P.; Won, H. H.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; Cownie, J.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Resistance to TRK inhibition mediated by convergent MAPK pathway activation
    Research Letter

    Cocco, E.; Schram, A. M.; Kulick, A.; Misale, S.; Won, H. H.; Yaeger, R.; Razavi, P.; Ptashkin, R.; Hechtman, J. F.; Toska, E.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save